English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 849198 Online Users : 1644
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
陳尚鴻
--會議論文/會議摘要
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
陳尚鴻
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
會議論文/會議摘要
[
6
/9]
期刊論文
[
39
/39]
Siblings
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Community Statistics
近3年內發表的文件:21(43.75%)
含全文筆數:45(93.75%)
文件下載次數統計
下載大於0次:45(100.00%)
下載大於100次:37(82.22%)
檔案下載總次數:11330(0.21%)
最後更新時間: 2024-11-28 13:30
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
DKK1 as a chemoresistant protein mo...
Comprehensive genomic profiling and...
Predictive value of FCGBP expressio...
Epstein-barr virus BRLF1 induces PD...
Germline mutations of homologous re...
The prognostic role of LAG-3 expres...
Topical antibiotic prophylaxis for ...
Phase 1 studies of D07001-F4 and D0...
The emergence of RAS mutations in p...
Dual role of sprouty2 as an inhibit...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-10 of 48. (5 Page(s) Totally)
1
2
3
4
5
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-09-27
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer
Oncogenesis. 2024 Sep 27;13:Article number 34.
2024-06-19
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer
Cancer Medicine. 2024 Jun 19;13(12).
2024-05-03
Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy
Aging. 2024 May 03;16(9):7889-7901.
2024-03-15
Epstein-barr virus BRLF1 induces PD-L1 expression in nasopharyngeal carcinoma cells
Viral Immunology. 2024 Mar 15;37(2):115-123.
2024-02-13
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan
Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02
Topical antibiotic prophylaxis for preventing surgical site onfections of clean wounds: A systematic review and meta-analysis
Surgical Infections. 2024 Feb;25(1):32-38.
2023-11
The prognostic role of LAG-3 expression in metastatic colorectal cancer
Annals of Oncology. 2023 Nov;34(Suppl. 4):S1514-S1515.
2023-10
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: A noninterventional, uncontrolled multicenter study
British Journal of Cancer. 2023 Oct;129(6):947-955.
2023-07
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer
Molecular Carcinogenesis. 2023 Jul;62(7):951-962.
2023-06
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors
Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
Showing items 1-10 of 48. (5 Page(s) Totally)
1
2
3
4
5
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback